A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: Results of the NSABP Protocol C-07.

Reviewer: Christopher Dolinsky, MD
University of Pennsylvania School of Medicine
Ultima Vez Modificado: 16 de mayo del 2005

Translation for this article does not exist


Where Are the Adults in the Room?
by Rodney Warner, JD
November 20, 2015

Related News

Addition of Oxaliplatin Ups Survival in Stage II/III Colon CA

Aug 30, 2011

FULV plus oxaliplatin ups disease-free survival; overall survival improves only in patients <70 years

Bevacizumab Doesn't Prolong Survival in Stage II-III Colon CA

Dec 12, 2012

One-year of adjuvant bevacizumab + FOLFOX6 has no benefit on disease-free, overall survival

Oxaliplatin Improves Survival for Colorectal Cancer Patients

Jan 26, 2012

Improvements found in community settings, even amongst older and minority populations